Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Leibowitz

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Ophthalmology|October 1, 1984
Evidence for mitosis in the adult corneal endotheliumR A Laing, L Neubauer, S S Oak, et al.
Clinical Pharmacology and Therapeutics|December 1, 1981
Cardiac effects of pergolideM Leibowitz, A Lieberman, M Goldstein, et al.
The Laryngoscope|February 18, 2020
High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: Risk Factors for Recurrence and Impact of Adjuvant TreatmentSamuel J Trosman, Angela Zhu, Elizabeth A Nicolli, et al.
Investigative Ophthalmology & Visual Science|July 1, 1990
In vitro evaluation of fibroplasia in a porous polymerV Trinkaus-Randall, J Capecchi, L Sammon, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1984
Coalescence of endothelial cells in the traumatized cornea. III. Correlation between specular and scanning electron microscopyL Neubauer, R S Baratz, R A Laing, et al.
Neurology|June 1, 1981
Treatment of advanced Parkinson disease with pergolideA Lieberman, M Goldstein, M Leibowitz, et al.
European Neurology|January 1, 1983
Further studies with lisuride in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
The American Journal of the Medical Sciences|September 1, 1985
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson diseaseA N Lieberman, M Leibowitz, G Gopinathan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1982
The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsyA Neophytides, A N Lieberman, M Goldstein, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
The use of pergolide, a potent dopamine agonist, in Parkinson's diseaseA N Lieberman, M Goldstein, A Neophytides, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Ophthalmology|October 1, 1984
Evidence for mitosis in the adult corneal endotheliumR A Laing, L Neubauer, S S Oak, et al.
Clinical Pharmacology and Therapeutics|December 1, 1981
Cardiac effects of pergolideM Leibowitz, A Lieberman, M Goldstein, et al.
The Laryngoscope|February 18, 2020
High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: Risk Factors for Recurrence and Impact of Adjuvant TreatmentSamuel J Trosman, Angela Zhu, Elizabeth A Nicolli, et al.
Investigative Ophthalmology & Visual Science|July 1, 1990
In vitro evaluation of fibroplasia in a porous polymerV Trinkaus-Randall, J Capecchi, L Sammon, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1984
Coalescence of endothelial cells in the traumatized cornea. III. Correlation between specular and scanning electron microscopyL Neubauer, R S Baratz, R A Laing, et al.
Neurology|June 1, 1981
Treatment of advanced Parkinson disease with pergolideA Lieberman, M Goldstein, M Leibowitz, et al.
European Neurology|January 1, 1983
Further studies with lisuride in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
The American Journal of the Medical Sciences|September 1, 1985
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson diseaseA N Lieberman, M Leibowitz, G Gopinathan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1982
The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsyA Neophytides, A N Lieberman, M Goldstein, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
The use of pergolide, a potent dopamine agonist, in Parkinson's diseaseA N Lieberman, M Goldstein, A Neophytides, et al.
Pageof 13